MedPath

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Phase 3
Withdrawn
Conditions
Leiomyomas
Interventions
Registration Number
NCT01553123
Lead Sponsor
Watson Pharmaceuticals
Brief Summary

The purpose of this study is to determine whether ulipristal acetate is effective in the treatment of females with anemia associated with uterine leiomyomas. The safety of this product will also be evaluated.

Detailed Description

This is a randomized, placebo controlled, multicenter study with parallel groups in order to evaluate the efficacy and safety of ulipristal acetate in female subjects with anemia associated with uterine leiomyomas. The objective of this study is to determine if daily ulipristal acetate with iron is more effective than iron alone.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Is a pre-menopausal female, 18 - 50 years;
  • Has documented leiomyoma(s);
  • Has leiomyoma-related anemia;
  • Has an endometrial biopsy within the screening period prior to the first dose of the test article which shows no endometrial hyperplasia;
  • Is willing and able to provide written informed consent and authorization to disclose protected health information.
Exclusion Criteria
  • Has a history of uterine surgery that would interfere with the study;
  • Has a condition requiring immediate or intermittent blood transfusions;
  • Has a known coagulation disorder;
  • Has a history of uterine, cervix, ovarian, or breast cancer;
  • Has used a selective progesterone receptor modulator or a gonadotrophin releasing hormone agonist in previous 6 months;
  • Has received blood transfusion within 8 weeks before the screening visit;
  • Has abnormal liver functions;
  • Is pregnant.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ulipristal with ironUlipristal Acetate-
Ulipristal with ironIron-
PlaceboIronPlacebo with iron
Primary Outcome Measures
NameTimeMethod
Change from baseline in hemoglobin levels (g/dL)Day 1 of the first on-treatment menstrual cycle to the start, or scheduled start of menstrual cycle 3.

Change from baseline in hemoglobin levels (g/dL)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (46)

Discovery Clinical Trials - Genesis Health Central Women's Care

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

Lawrence Obstetrics-Gynecology Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Lawrenceville, New Jersey, United States

Columbus Center for Women's Health Research

๐Ÿ‡บ๐Ÿ‡ธ

Columbus, Ohio, United States

Office of Annette Mayes, MD, PC

๐Ÿ‡บ๐Ÿ‡ธ

Las Vegas, Nevada, United States

Office of Edmond Pack, MD

๐Ÿ‡บ๐Ÿ‡ธ

Las Vegas, Nevada, United States

Office of R. Garn Mabey, Jr

๐Ÿ‡บ๐Ÿ‡ธ

Las Vegas, Nevada, United States

Advances in Health Inc

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

Sharp Rees-Stealy Medical Group

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, California, United States

Alabama Clinical Therapeutics

๐Ÿ‡บ๐Ÿ‡ธ

Birmingham, Alabama, United States

Women's Health Research

๐Ÿ‡บ๐Ÿ‡ธ

Phoenix, Arizona, United States

Medical Center for Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, California, United States

Hutzel Womens Health Specialists

๐Ÿ‡บ๐Ÿ‡ธ

Detroit, Michigan, United States

Clinical Trials of Texas Incorporated Laboratory

๐Ÿ‡บ๐Ÿ‡ธ

San Antonio, Texas, United States

Downtown Women's Health Care

๐Ÿ‡บ๐Ÿ‡ธ

Denver, Colorado, United States

Visions Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Boynton Beach, Florida, United States

Healthcare Clinical Data, Inc.

๐Ÿ‡บ๐Ÿ‡ธ

North Miami, Florida, United States

South Bend Clinical

๐Ÿ‡บ๐Ÿ‡ธ

Granger, Indiana, United States

Benchmark Research

๐Ÿ‡บ๐Ÿ‡ธ

Sacramento, California, United States

Coastal Clinical Research, Inc

๐Ÿ‡บ๐Ÿ‡ธ

Mobile, Alabama, United States

Altus Research

๐Ÿ‡บ๐Ÿ‡ธ

Lake Worth, Florida, United States

Jacksonville Center for Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Jacksonville, Florida, United States

Atlanta Women's Research Institute, Inc

๐Ÿ‡บ๐Ÿ‡ธ

Atlanta, Georgia, United States

Comprehensive Clinical Trials, LLC

๐Ÿ‡บ๐Ÿ‡ธ

West Palm Beach, Florida, United States

Fellows Research Alliance

๐Ÿ‡บ๐Ÿ‡ธ

Savannah, Georgia, United States

Women's Health Practice

๐Ÿ‡บ๐Ÿ‡ธ

Champaign, Illinois, United States

All Women's Healthcare of West Broward

๐Ÿ‡บ๐Ÿ‡ธ

Plantation, Florida, United States

Physician Care Clinical Research, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Sarasota, Florida, United States

Praetorian Pharmaceutical Research, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Marrero, Louisiana, United States

Center for Women's Research

๐Ÿ‡บ๐Ÿ‡ธ

Palos Heights, Illinois, United States

Mount Vernon Clinical Research, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Sandy Springs, Georgia, United States

Women Under Study, LLC

๐Ÿ‡บ๐Ÿ‡ธ

New Orleans, Louisiana, United States

Advanced Gynecologic Surgery Institute

๐Ÿ‡บ๐Ÿ‡ธ

Naperville, Illinois, United States

New York Center for Women's Health Research

๐Ÿ‡บ๐Ÿ‡ธ

New York City, New York, United States

Women's Clinic of Lincoln, P.C.

๐Ÿ‡บ๐Ÿ‡ธ

Lincoln, Nebraska, United States

Carolina Women's Research and Wellness Center

๐Ÿ‡บ๐Ÿ‡ธ

Durham, North Carolina, United States

Southwest Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Albuquerque, New Mexico, United States

Physicians for Women of Greensboro

๐Ÿ‡บ๐Ÿ‡ธ

Greensboro, North Carolina, United States

Eastern Carolina Women's Center

๐Ÿ‡บ๐Ÿ‡ธ

New Bern, North Carolina, United States

PMG Research of Wilmington

๐Ÿ‡บ๐Ÿ‡ธ

Wilmington, North Carolina, United States

Wake Research Associates

๐Ÿ‡บ๐Ÿ‡ธ

Raleigh, North Carolina, United States

Hawthorne Medical Research

๐Ÿ‡บ๐Ÿ‡ธ

Winston-Salem, North Carolina, United States

Southeast Regional Research Group

๐Ÿ‡บ๐Ÿ‡ธ

Aiken, South Carolina, United States

Advanced Clinical Concepts

๐Ÿ‡บ๐Ÿ‡ธ

West Reading, Pennsylvania, United States

South Carolina Clinical Research Center, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Columbia, South Carolina, United States

Willowbend Health and Wellness Associates

๐Ÿ‡บ๐Ÿ‡ธ

Plano, Texas, United States

Riverside Regional Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Newport News, Virginia, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath